![]()
One of the most common hormonal conditions affecting women worldwide just got a new name — and it is about time.
On May 12, 2026, a global medical consensus published in The Lancet officially renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). The announcement was made at the European Congress of Endocrinology in Prague, and it marks the conclusion of a 14-year collaborative effort involving clinicians, researchers, and patients from six continents.
This is not a cosmetic update. It is a recognition that the condition was fundamentally misnamed — and that the old name was actively harming millions of women by delaying their diagnosis, reducing their condition to “a problem with the ovaries,” and causing them to question whether they even had it at all.
At Mata Sahib Kaur College of Nursing, Balongi, Mohali, we believe nursing professionals and nursing students need to understand this change deeply — because PMOS is a condition that nurses will encounter across their entire careers, in gynaecology wards, endocrine clinics, community health centres, and OPDs. And more immediately: millions of young women in India are living with this condition right now — possibly without knowing it.
Let’s break it down clearly.
Table of Contents
TogglePCOS — Polycystic Ovary Syndrome — was a name that described the condition primarily through what doctors saw on an ultrasound: what appeared to be multiple “cysts” on the ovaries. But this was always incomplete and, in many cases, outright misleading.
Here is the scientific reality:
The new name — Polyendocrine Metabolic Ovarian Syndrome (PMOS) — was chosen to reflect this reality accurately:
The diagnostic criteria have not changed. If you were diagnosed with PCOS before May 2026, your diagnosis is still valid. The condition is the same. What has changed is how accurately it is now named — and what that accuracy means for how it is understood, diagnosed, and treated.
PMOS affects more than 170 million women worldwide — that is more than 1 in 8 women of reproductive age globally.
In India, the picture is alarming. Studies estimate prevalence rates ranging from 3.7% to over 22% depending on the region and diagnostic method — and researchers widely believe that actual rates are much higher because the condition is vastly underdiagnosed. Indian women with PMOS also appear to face higher metabolic complications at younger ages compared to women in Western populations.
The reasons for underdiagnosis in India include:
The symptoms of PMOS are the same as what was previously described as PCOS:
Hormonal and reproductive:
Metabolic:
Mental health:
To receive a diagnosis, a patient must exhibit at least two of three criteria: irregular ovulation; elevated androgen levels; or ultrasound showing 20 or more antral follicles.
This is the part that matters most — and the reason this name change took 14 years to bring about.
When a condition is named after a symptom that many patients don’t even have, what happens? Patients go to doctors saying “I have irregular periods and acne and I can’t lose weight” — and the doctor orders an ultrasound, finds no visible cysts, and tells them they don’t have PCOS. End of consultation.
The patient leaves confused. Her real symptoms — the insulin resistance, the androgen excess, the hormonal disruption — go unaddressed. She spends years managing what she thinks are separate, unconnected problems: the skin issues, the weight, the mood, the fatigue.
This happened to millions of women. The misunderstanding was not the patient’s fault. It was built into the name.
As NIH experts noted in supporting documentation for the renaming: “The name focuses on a criterion — polycystic ovarian morphology — which is neither necessary nor sufficient to diagnose the syndrome”.
The new name, PMOS, removes that trap. It signals to clinicians and patients alike that this condition is systemic — and that diagnosis should not depend on finding cysts.
The treatment approach for PMOS remains what it was for PCOS:
Lifestyle management (first-line for most patients):
Medical management (where needed):
Multidisciplinary care (the gold standard):
Here is what is not discussed enough in nursing education — and what the renaming of this condition now makes impossible to ignore: PMOS is not just a gynaecology problem. It is a community health problem, a metabolic health problem, and a mental health problem.
That means nurses encounter it everywhere.
In community health settings (ANM and GNM trained nurses):
A community health nurse conducting maternal health screenings, school health programmes, or anganwadi visits is often the first point of contact for a young woman with undiagnosed PMOS. The ability to recognise symptoms — irregular cycles, unexplained weight gain, skin changes, fatigue — and refer appropriately can mean the difference between early management and a decade of unaddressed metabolic damage.
In OPDs and general medicine wards (B.Sc Nursing and GNM):
A ward nurse who understands that PMOS is a metabolic condition will know to monitor blood glucose, blood pressure, and weight trends as part of routine care — not just ask about periods. This is clinical knowledge that makes a difference.
In mental health and counselling contexts:
Nurses trained in mental health nursing will increasingly encounter PMOS as a comorbid condition. The anxiety, depression, and body image distress associated with PMOS are not secondary — they are part of the syndrome and require as much clinical attention as the hormonal symptoms.
In gynaecology and endocrinology specialisations:
For B.Sc Nursing graduates pursuing specialisation — or for M.Sc Nursing students in Obstetrics & Gynaecological Nursing — PMOS management will be a core clinical skill set. The shift to PMOS framing will require nurses to assess and document a broader set of parameters, coordinate with multi-disciplinary teams, and support patient education around a condition that most women still misunderstand.
The transition to PMOS will be phased over three years and fully integrated into the 2028 International Guideline update. During this transition:
This is precisely the kind of update that nursing education must stay ahead of. At Mata Sahib Kaur College of Nursing, Mohali, we incorporate current clinical knowledge into our teaching — because the nurses we train will be working in wards and communities where this transition is already beginning.
If you have been told you might have PCOS — or if you have symptoms like irregular periods, unexplained weight changes, acne, facial hair, fatigue, or difficulty managing your weight — this name change is relevant for you.
It does not change your diagnosis. But it does change the conversation you can now have with your doctor.
You are no longer looking for cysts on an ultrasound as the defining proof of your condition. PMOS is a hormonal and metabolic syndrome — and it can be identified, managed, and treated based on your full symptom picture.
Ask for a full assessment. Ask about insulin resistance. Ask about your androgen levels. Ask about the mental health component. Ask to be seen completely — not partially.
You deserve a diagnosis that reflects the full reality of what you are living with.
At Mata Sahib Kaur College of Nursing, Balongi, Mohali, we train nurses who stay current with global developments in healthcare — because their patients will need them to. If you are a student or a professional who would like to learn more about our nursing programmes, visit